IL-11/IL-11R Signal Inhibition by 9MW3811 Remodels Immune Tumor Microenvironment and Enhances Anti-Tumor Efficacy of PD-1 Blockade

0
105
Scientists introduced 9MW3811, a monoclonal antibody designed to neutralize IL-11 effectively.
[NPJ Precision Oncology]
Full Article